Eli Lilly and Company (LLY) to Distribute Quarterly Dividend of $1.73 on September 10th

Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend on Monday, June 22nd. Investors of record on Friday, August 14th will be paid a dividend of 1.73 per share on Thursday, September 10th. This represents a c) annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, August 14th.

Eli Lilly and Company has increased its dividend payment by an average of 0.2%annually over the last three years and has raised its dividend annually for the last 11 consecutive years. Eli Lilly and Company has a dividend payout ratio of 23.3% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Eli Lilly and Company to earn $44.60 per share next year, which means the company should continue to be able to cover its $6.92 annual dividend with an expected future payout ratio of 15.5%.

Eli Lilly and Company Trading Up 0.8%

LLY opened at $1,110.37 on Wednesday. The company has a quick ratio of 1.10, a current ratio of 1.50 and a debt-to-equity ratio of 1.26. The stock’s fifty day moving average is $1,022.46 and its two-hundred day moving average is $1,018.08. The company has a market capitalization of $1.05 trillion, a P/E ratio of 39.44, a PEG ratio of 1.20 and a beta of 0.53. Eli Lilly and Company has a 52 week low of $623.78 and a 52 week high of $1,182.73.

Eli Lilly and Company (NYSE:LLY) last posted its quarterly earnings results on Thursday, April 30th. The company reported $8.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.97 by $1.58. The business had revenue of $19.80 billion for the quarter, compared to the consensus estimate of $17.82 billion. Eli Lilly and Company had a return on equity of 105.77% and a net margin of 34.98%.The business’s revenue was up 55.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.34 EPS. Eli Lilly and Company has set its FY 2026 guidance at 35.500-37.000 EPS. Analysts forecast that Eli Lilly and Company will post 35.8 earnings per share for the current year.

Eli Lilly and Company Company Profile

Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana. The company researches, develops, manufactures and commercializes a broad range of medicines and therapies for patients worldwide. Eli Lilly maintains operations and commercial presence across North America, Europe, Asia and other regions, serving both developed and emerging markets. The company has been led in recent years by President and Chief Executive Officer David A.